Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

balofloxacin MeSH Supplementary Concept Data 2025


MeSH Supplementary
balofloxacin
Unique ID
C077155
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C077155
Entry Term(s)
1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylaminopiperidine-1-yl)-4-oxoquinoline-3-carboxylic acid
Q 35
Q-35
Pharm Action
Anti-Bacterial Agents
Topoisomerase II Inhibitors
Registry Numbers
Q022B63JPM
Related Numbers
127294-70-6
CAS Type 1 Name
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-(methylamino)-1-piperidinyl)-4-oxo-
Heading Mapped to
*Fluoroquinolones
Frequency
43
Note
showed potent bactericidal activity & inhibited the supercoiling activity of DNA gyrase of S. aureus, E. coli, & P aeruginosa; structure given in first source
Source
Antimicrob Agents Chemother 1992 Aug;36(8):1708-14
Date of Entry
1992/11/05
Revision Date
2013/05/22
balofloxacin Preferred
Q 35 Narrower
page delivered in 0.004s